Two-year #postdoc position open: Join to Our Group #Hepatology Lab at CIMA in Pamplona. Investigate #Liver Cancer and unveil the #Epigenetic mechanisms involved. Collaborate with Leaders in #liverTumors and #Immunotherapies. Contact by DM. RT appreciated.

It was a pleasure having you here at UPEC and thank you again for making these challenging topics so simple!

Hi, for people in the Torino to attend #EACR2023, if you’re interested in liver cancer, I have a poster about refining of HCC subtypes today #P-0414. I will be there after 5pm. Feel free to come by and say hi😊😊😉!

Our last work "Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab" was just released in journal of hepatology Journal of Hepatology @CRCordeliers Jessica Zucman-Rossi journal-of-hepatology.eu/article/S0168-…

If you want to know what is hidden behind Long Pan | 潘龙, go see his poster at the #ILCA23 in Amsterdam!! Stefano Caruso @CRCordeliers

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study - The Lancet Oncology by ⁦@Caldera60373705⁩ ! thelancet.com/journals/lanon…

Don’t hesitate to register for this free event later today!! We’ll discuss the challenges of Molecular Tumor Boards for Hepatocellular Carcinoma #LiverTwitter

Recently published: Jakob Nikolas Kather @Caldera60373705 Stefano Caruso Narmin Ghaffari Laleh Qinghe ZENG use #DeepLearning to re-classify combined hepatocellular-cholangiocarcinomas using histopathology #LiverCancer #CancerResearch Cancer at Nature Portfolio nature.com/articles/s4146…

Some personal news: I’ve secured a permanent research position at Inserm so I'll be able to continue working with this happy bunch of the FunGeST team in the wonderful @CRCordeliers ! Stay tuned for scientific updates on the genomics of pediatric and adult liver cancer!

🚀 It's AI Day #EASL2024 designed by our AI Task Force easl.eu/easl/leadershi… 📅 🧠 Research in the Era of AI 🕰️ 08:30 - 09:45 🌟 Studio: AI Liver Taskforce 🕰️ 12:30 - 13:00 🤖 AI in Clinical Care 🕰️ 17:15 - 18:15  EASLnews Ahmed Elsharkawy Aleksander Krag @Caldera60373705

What a fun session at EASL Education EASLnews #EASLcongress 2024 about "Research in the age of AI" in Milan 🇮🇹🇪🇺. Any biomedical researcher should be aware of current AI tools and develop a basic literacy. TU Dresden Nationales Centrum für Tumorerkrankungen Dresden NCT Heidelberg @Medizin_TUD Universitätsklinikum Heidelberg

Up next, Dr. Stefano Caruso Stefano Caruso dives into the integration of digital pathology and spatial genomics in liver cancer research and diagnostics at #PrecisionBTCNet #ENSCCA #Krakow2024. 🔬🇵🇱

Artificial intelligence for BTC management. Such brilliant talks regarding the application in BTC of this powerful technology. Precision-BTC-Network @UCPHAndersenLab Stefano Caruso Hannah Sophie Muti, MD #LucaViganó #ensccaPrecisionBTCNetworkJointmeeting

Thank you once again to all our attendees for making the ENSCCA/Precision-BTC-Network Joint Meeting an unforgettable event! Your energy and contributions made it truly special. Thank you Krakow for hosting us! 🇵🇱 Looking forward to our next gathering! #ENSCCA #PrecisionBTCNet

This week, we hosted another summer school of medical AI at TU Dresden @Medizin_TUD - led by Narmin Ghaffari Laleh 🤩 with dozens of participants from research teams in 🇮🇹🇫🇷🇷🇴🇩🇪🇺🇸 & plenty of discussions, memes & new research ideas 🌟 Funded by 🇪🇺 via tangerine-ai.eu

Thank you Cancéropôle IDF for the invitation to discuss spatial transcriptomics today in Paris! Very nice presentations and discussions!

At #LiverCancerSummit, Stefano Caruso introduced the transformative potential of spatial omics in liver cancer research. This emerging field offers unprecedented insights into tumor heterogeneity, microenvironment interactions, and high-resolution biomarker identification. With

📍 Cluj-Napoca, Romania. The European TANGERINE consortium, led by Dr. Víctor Moreno (IDIBELL /Institut Català d'Oncologia ), met to review progress on an AI tool that predicts immunotherapy response and toxicity in cancer patients. 🔬 A step forward in #PersonalizedMedicine, driven by

🎓 New Webinar Series: Artificial Intelligence in Oncology 🤝 #HeCOG & EU Interdisc. Society of AI for Cancer Research join forces for a monthly webinar series on how #AI is transforming #oncology. 🧠 Learn from leading experts, explore real-world clinical applications & the future of cancer care. 📅 Nov 4, 2025

One year after its launch, ESAC announces its 1st Annual Meeting. 📅 May 7–8, 2026 📍 Politecnico di Milano (Via Bonardi 9, 20133 Milan) 📢 Call for abstracts open until Feb 3, 2026 For details, visit the conference's website aiforoncology.it Registrations opening soon